Hepatocellular carcinoma: A prime indication for living donor liver transplantation

Journal of Gastrointestinal Surgery

Volumn 6, Issue 1, 2002, Pages 102-107

  Gondolesi, Gabriel ^a   Muñoz, Luis ^a   Matsumoto, Cal ^a   Fishbein, Thomas ^a   Sheiner, Patricia ^a   Emre, Sukru ^a   Miller, Charles ^a   Schwartz, Myron E ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

HCC; Living donor; Transplantation

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN; TSUKUBAENOLIDE;

ADULT; AGED; CADAVER DONOR; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIMARY BILIARY CIRRHOSIS; PROTEIN DETERMINATION; REVIEW; SINGLE DRUG DOSE; TREATMENT INDICATION; ARTICLE; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; GRAFT REJECTION; GRAFT SURVIVAL; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036372074     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)00024-5     Document Type: Article

References (24)

1. Okuda K. Hepatocellular carcinoma: Recent progress. Hepatology 1992;15:948-963.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
3. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
4. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: A study in 22 patients. Gastroenterology 1986;90:289-298.
5. Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-137.
6. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-928.
7. Calvet X, Bruix J, Bru C, et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J Hepatol 1990;16:6-72.
8. Llovet JM, Bustamante J, Castells A, et al. Liver transplantation for hepatocellular carcinoma. Results of a restrictive policy [abstr]. Hepatology 1996;24:350A.
9. Schwartz ME, Sung M, Fisher A, et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995;180:596-603.
10. Schiano TD, Kim-Schluger L, Gondolesi G, Miller CM. Adult living donor liver transplantation: The hepatologist's perspective. Hepatology 2000;33:3-10.
11. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389-394.
12. Otto G, Heuschen U, Hofmann WJ, et al. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. A retrospective analysis. Ann Surg 1998;227:424-432.
13. Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151.
14. Klintmalm G. Liver transplantation for hepatocellular carcinoma. A registry report of impact of tumor characteristics on outcome. Ann Surg 1998;228:479-490.
15. Yamamoto J, Iwatsuki S, Kosuge T, et al. Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999;86:1151-1158.
16. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;14:728-729.
17. Roayaie S, Ben Haim M, Emre S, et al. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B vs hepatitis C: A western experience. Ann Surg Oncol 2000;7:764-770.
18. Choi B. CT diagnosis of liver cancer. In Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone, 1997, pp 371-391.
19. Broelsch CE, Burdelski M, Rogiers X, et al. Living donor for liver transplantation. Hepatology 1994;20:49(s).
20. Yamaoka Y, Washida M, Honda K, et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation 1994;7:1127-1130.
21. Marcos A. Right lobe living donor liver transplantation: A review. Liver Transpl 2000;6:3-20.
22. Sheung-Tat F. Donor safety in living donor liver transplantation. Liver Transpl 2000;6:251.
23. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-703.
24. Liou TC, Shih SC, Kao CR, et al. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995;23:563-568.